These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

604 related items for PubMed ID: 29036791

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. PD-L1 expression and tumor mutational burden status for prediction of response to chemotherapy and targeted therapy in non-small cell lung cancer.
    Chen Y, Liu Q, Chen Z, Wang Y, Yang W, Hu Y, Han W, Zeng H, Ma H, Dai J, Zhang H.
    J Exp Clin Cancer Res; 2019 May 14; 38(1):193. PubMed ID: 31088500
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [A Real-world Study on the Assessment of Pathological Characteristics and Targeted Therapeutic Effect of Non-small Cell Lung Cancer Patients with Positive Driving Genes and High PD-L1 Expression].
    Zhang H, Yang X, Li K, Wang J, Lv J, Li X, Zhang X, Qin N, Zhang Q, Wu Y, Ma L, Gai F, Hu Y, Zhang S.
    Zhongguo Fei Ai Za Zhi; 2021 Feb 20; 24(2):78-87. PubMed ID: 33478196
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Predictive value of oncogenic driver subtype, programmed death-1 ligand (PD-L1) score, and smoking status on the efficacy of PD-1/PD-L1 inhibitors in patients with oncogene-driven non-small cell lung cancer.
    Ng TL, Liu Y, Dimou A, Patil T, Aisner DL, Dong Z, Jiang T, Su C, Wu C, Ren S, Zhou C, Camidge DR.
    Cancer; 2019 Apr 01; 125(7):1038-1049. PubMed ID: 30548240
    [Abstract] [Full Text] [Related]

  • 11. Relationship between driver gene mutations, their relative protein expressions and survival in non-small cell lung carcinoma in Macao.
    Chan KI, Vong HT, Sin LF, Yip YC, Zhong XY, Wen JM.
    Clin Respir J; 2018 Apr 01; 12(4):1416-1423. PubMed ID: 28756651
    [Abstract] [Full Text] [Related]

  • 12. LAG-3 Protein Expression in Non-Small Cell Lung Cancer and Its Relationship with PD-1/PD-L1 and Tumor-Infiltrating Lymphocytes.
    He Y, Yu H, Rozeboom L, Rivard CJ, Ellison K, Dziadziuszko R, Suda K, Ren S, Wu C, Hou L, Zhou C, Hirsch FR.
    J Thorac Oncol; 2017 May 01; 12(5):814-823. PubMed ID: 28132868
    [Abstract] [Full Text] [Related]

  • 13. Retrospective Molecular Epidemiology Study of PD-L1 Expression in Patients with EGFR-Mutant Non-small Cell Lung Cancer.
    Cho JH, Zhou W, Choi YL, Sun JM, Choi H, Kim TE, Dolled-Filhart M, Emancipator K, Rutkowski MA, Kim J.
    Cancer Res Treat; 2018 Jan 01; 50(1):95-102. PubMed ID: 28301925
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Correlation Study on Expression of PD-1 and PD-L1 in Non-small Cell Lung Cancer and Epidermal Growth Factor Receptor Mutations].
    Jiang L, Lin Z, Li N, Jiang J, Lu C, Du S, Zhang J, Wang Y, Chen J, Gong P.
    Zhongguo Fei Ai Za Zhi; 2021 Sep 20; 24(9):623-631. PubMed ID: 34455737
    [Abstract] [Full Text] [Related]

  • 16. Comprehensive molecular analysis of driver mutations in non-small cell lung carcinomas and its correlation with PD-L1 expression, An Indian perspective.
    Aggarwal A, Sharma S, Brar Z, Kumar V, Kumar A, Katara R, Mohanty SK.
    Pathol Res Pract; 2024 Jan 20; 253():155013. PubMed ID: 38096714
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Association of PD-L1 expression and PD-L1 gene polymorphism with poor prognosis in lung adenocarcinoma and squamous cell carcinoma.
    Yeo MK, Choi SY, Seong IO, Suh KS, Kim JM, Kim KH.
    Hum Pathol; 2017 Oct 20; 68():103-111. PubMed ID: 28851662
    [Abstract] [Full Text] [Related]

  • 20. PD-L1 expression, EGFR and KRAS mutations and survival among stage III unresected non-small cell lung cancer patients: a Danish cohort study.
    Cronin-Fenton D, Dalvi T, Movva N, Pedersen L, Hansen H, Fryzek J, Hedgeman E, Mellemgaard A, Rasmussen TR, Shire N, Hamilton-Dutoit S, Nørgaard M.
    Sci Rep; 2021 Aug 19; 11(1):16892. PubMed ID: 34413420
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.